—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
JAMA Ophthalmology《眼科学纪要》
月刊 - 美国
  • JAMA Ophthalmology《眼科学纪要》
  • SCIE外文期刊
  • 期发文量26
  • 国人占比10.26%
  • 维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:1区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:3
    环比增速:-80.00%
  • 期刊信息

  • 研究方向:医学-OPHTHALMOLOGY 眼科学
  • 国际刊号:ISSN2168-6165;EISSN2168-6173
  • 期刊语言:英语
    出版地区:美国
  • 投稿网址:https://manuscripts.jamaophth.com/
  • 电子邮箱:
  • 期刊官网:https://jamanetwork.com/journals/jamaophthalmology
  • 作者指南:
  • 出版商网址:http://www.ama-assn.org
  • 出版地址:330 N WABASH AVE, STE 39300, CHICAGO, USA, IL, 60611-5885
  • 期刊简介:JAMA Ophthalmology《眼科学纪要》(月刊). JAMA Ophthalmology, published continuously since 1869, is an international, peer-reviewed ophthalmology and visual science journal. In 2019, the journal celebrates 150 years of continuous publication. JAMA Ophthalmology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

  • 万维提示


  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://jamanetwork.com/journals/jamaophthalmology

    3、投稿网址:https://manuscripts.jamaophth.com/

    4、官网邮箱:jamaophth@jamanetwork.org

    5、官网电话:(410) 955-6494

    6、期刊刊期:月刊,一年出版12期。

    2021717日星期六

                                     

     

    投稿须知【官网信息】

     

    For Authors

    About JAMA Ophthalmology

    JAMA Ophthalmology, published continuously since 1869, is an international, peer-reviewed ophthalmology and visual science journal. In 2019, the journal celebrates 150 years of continuous publication. JAMA Ophthalmology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

    Journal Frequency and Access. JAMA Ophthalmology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives over 2.6 million online visits annually and more than 3.3 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.

    Editorial Information. The journal’s acceptance rate is 10%. The median time to first decision is 8 days, and 51 days with review. The journal's Impact Factor is 7.4, one of the highest ranking among ophthalmology journals. All articles are published online first. Additional information on the types of articles published and editorial policies is available in the journal's Instructions for Authors.

    Editorial Team. Neil M. Bressler, MD, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, is the editor in chief. For a complete listing of the journal's Editors and Editorial Board, see Editors and Publishers.

    Mission Statement: To be the indispensable source of ophthalmic knowledge for the generalist, subspecialist, and trainee; to publish innovative, clinically relevant research for the vision scientist; to be the first choice for authors to submit their important manuscripts to; and to achieve this through authoritative peer review.

    JAMA Ophthalmology

    ISSN 2168-6165 (Print)

    ISSN 2168-6173 (Online)

    Why Publish in JAMA Ophthalmology?

    JAMA Ophthalmology publishes innovative, clinically relevant research in vision science.

    Impact and Reach

    Impact Factor of 7.4, one of the highest ranking among ophthalmology journals

    Over 2.6 million annual visits to the JAMA Ophthalmology website; more than 3.3 million article views and downloads

    International authors: 67% of submissions come from outside the United States

    Extensive press coverage, with 4,800 media mentions in 2020 in outlets such as The New York Times, The Washington Post, Newsweek, CBS News, and Reuters

    Top Altmetric scores—JAMA Ophthalmology published 32 of the top 50 articles among ophthalmology journals, including the No. 1 article

    Number of citations, Altmetric score, page views, and PDF downloads tracked for your published article

    Broad reach through related commentary, author audio interviews, podcasts, email alerts, social media, multimedia, and more than 32,000 followers on Twitter and Facebook

    Prompt Decisions and Rapid Publication Timelines

    Highly selective peer review and editorial evaluation, with 10% acceptance rate for all submissions

    Median time to first decision: 8 days without external peer review; 51 days with review

    Online First publication of all articles

    Rapid publication of clinical trials, including those from the Age-Related Eye Disease Study (AREDS), AREDS2, Comparison of AMD Treatment Trials (CATT), Corneal Donor Study, Diabetic Retinopathy Clinical Research Network, Infant Aphakia Treatment Study Group, MARINA and ANCHOR investigators, Ocular Hypertension Treatment Group, Pediatric Eye Disease Investigators Group, SCORE2 Study Group, VIVID and VISTA investigators

    Author Service

    User-friendly manuscript submission system and process

    Prompt, expert review and consideration from our experienced editors

    Highest standards followed to improve your accepted manuscript's accuracy, reliability, and readability

    CME credit available for lead authors who publish in JAMA Ophthalmology

    Opportunity for your work to be augmented with expert illustration, interactive features, video, audio, and visual abstract

    Free public access: All research articles are free 12 months after publication on the journal's website

    Open access: Authors of research articles may elect to pay for immediate open access on the day of publication

    Direct deposit to PubMed Central: All research articles deposited directly in PubMed Central (PMC) for authors

    Online extras: Ability to post supplemental content online and download your article's tables and figures as PowerPoint slides

    The JAMA Network advantage: Authors of papers not accepted by JAMA Ophthalmology may have the option to have their papers and reviewers' comments automatically referred to one of the JAMA Network specialty journals and/or JAMA Network Open

    Authors of ophthalmology papers accepted by JAMA may have related commentaries in JAMA Ophthalmology

    Dedicated media team to promote your article to the news media and on social media

    JAMA Network journals welcome manuscript submissions on diversity, equity, and inclusion. For example, see the Health Disparities Topic Collection and the list of articles on race, racism, and racial/ethnic disparities/inequities published during the last 5 years here.

    For more information, see JAMA Ophthalmology Instructions for Authors. Submit your manuscript at https://manuscripts.jamaophth.com.

    Updated July 2021

    Instructions for Authors

    Contact Information

    JAMA Ophthalmology, Neil M. Bressler, MD, Editor, 600 N Wolfe St, Maumenee 715, Baltimore, MD 21287; telephone: (410) 955-6494; fax: (866) 542-4857; email: jamaophth@jamanetwork.org. Manuscripts should be submitted online at http://manuscripts.jamaophth.com.

    How Do I?

    Determine My Article Type

    Categories of Articles

    ……

    更多详情:

    https://jamanetwork.com/journals/jamaophthalmology/pages/for-authors




欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码